Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

OLMA

Olema Pharmaceuticals (OLMA)

Olema Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:OLMA
DateTimeSourceHeadlineSymbolCompany
08/09/20224:35PMGlobeNewswire Inc.Olema Oncology Reports Second Quarter 2022 Financial Results and Provides Corporate UpdateNASDAQ:OLMAOlema Pharmaceuticals Inc
08/09/20224:30PMGlobeNewswire Inc.Olema Oncology Advances OP-1250 into Phase 2 Monotherapy Expansion in Patients with ER+/HER2- Advanced Breast CancerNASDAQ:OLMAOlema Pharmaceuticals Inc
08/04/20224:30PMGlobeNewswire Inc.Olema Oncology to Present at Canaccord Genuity 42nd Annual Growth ConferenceNASDAQ:OLMAOlema Pharmaceuticals Inc
08/03/20224:30PMGlobeNewswire Inc.Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:OLMAOlema Pharmaceuticals Inc
07/21/20228:14AMDow Jones NewsOlema Oncology Gets FDA Fast-Track Designation for OP-1250NASDAQ:OLMAOlema Pharmaceuticals Inc
07/21/20227:30AMGlobeNewswire Inc.Olema Oncology Receives FDA Fast Track Designation for OP-1250 for the Treatment of ER+ / HER2- Metastatic Breast CancerNASDAQ:OLMAOlema Pharmaceuticals Inc
07/08/20225:00PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:OLMAOlema Pharmaceuticals Inc
07/07/202210:40AMTipRanks2 “Strong Buy” Penny Stocks That Could See Huge Long-Term GainsNASDAQ:OLMAOlema Pharmaceuticals Inc
07/06/202210:00PMTipRanksOlema Pharmaceuticals (OLMA) Gets a Buy Rating from Cowen & Co.NASDAQ:OLMAOlema Pharmaceuticals Inc
07/05/20224:30PMGlobeNewswire Inc.Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:OLMAOlema Pharmaceuticals Inc
06/27/20225:17PMEdgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:OLMAOlema Pharmaceuticals Inc
06/27/20225:15PMEdgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:OLMAOlema Pharmaceuticals Inc
06/27/20225:14PMEdgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:OLMAOlema Pharmaceuticals Inc
06/27/20225:11PMEdgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:OLMAOlema Pharmaceuticals Inc
06/23/20224:06PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OLMAOlema Pharmaceuticals Inc
06/17/20227:32PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OLMAOlema Pharmaceuticals Inc
06/17/20227:31PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OLMAOlema Pharmaceuticals Inc
06/17/20227:30PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OLMAOlema Pharmaceuticals Inc
06/17/20227:29PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OLMAOlema Pharmaceuticals Inc
06/17/20227:28PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OLMAOlema Pharmaceuticals Inc
06/17/20227:26PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OLMAOlema Pharmaceuticals Inc
06/17/20227:26PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OLMAOlema Pharmaceuticals Inc
06/14/20224:47PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OLMAOlema Pharmaceuticals Inc
06/14/202210:25AMTipRanksOlema Pharmaceuticals (OLMA) Gets a Buy Rating from LifeSci CapitalNASDAQ:OLMAOlema Pharmaceuticals Inc
06/09/20228:49AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OLMAOlema Pharmaceuticals Inc
06/09/20227:35AMGlobeNewswire Inc.Olema Oncology Provides Clinical Update Reflecting Strong Progress Across OP-1250 Development ProgramNASDAQ:OLMAOlema Pharmaceuticals Inc
06/09/20227:30AMGlobeNewswire Inc.Olema Oncology and Aurigene Announce Exclusive Collaboration and License Agreement to Discover and Develop Novel Cancer TherapiesNASDAQ:OLMAOlema Pharmaceuticals Inc
06/02/20224:30PMGlobeNewswire Inc.Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:OLMAOlema Pharmaceuticals Inc
05/25/20229:36AMTipRanksAnalysts Offer Insights on Healthcare Companies: Olema Pharmaceuticals (OLMA) and Cincor Pharma (CINC)NASDAQ:OLMAOlema Pharmaceuticals Inc
05/24/20224:30PMGlobeNewswire Inc.Olema Oncology to Present at Jefferies Healthcare ConferenceNASDAQ:OLMAOlema Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:OLMA